Targeting Apoptosis Pathways in Cancer Therapy
Novel Agents on the Horizon for Cancer Therapy
Breast cancer statistics 2024
A review: recent developments of co-targeted TRK (tropomyosin receptor kinases) inhibitors for cancer therapy